Premenstrual Syndrome Treatment Market: The Path Toward a 5% CAGR Growth by 2030
The global premenstrual syndrome treatment market is expected to grow at a CAGR of around 5% during the forecast period. This growth is driven by increasing awareness of PMS and the rising number of individuals seeking treatment for associated symptoms. The expanding availability of over-the-counter solutions and prescription drugs is contributing to market growth. Innovations in […]
Continue Reading